Oral disease-modifying therapies for multiple sclerosis in the Middle Eastern and North African (MENA) region: an overview-Reference-Cited by-同舟云学术

Oral disease-modifying therapies for multiple sclerosis in the Middle Eastern and North African (MENA) region: an overview

Published:2018-06-18 Issue:2 Volume:35 Page:249-260
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Deleu Dirk¹,Mesraoua Boulenouar¹,Canibaño Beatriz¹,Melikyan Gayane¹,Al Hail Hassan¹,El-Sheikh Lubna¹,Ali Musab¹,Al Hussein Hassan¹,Ibrahim Faiza¹,Hanssens Yolande²

Affiliation:

1. Department of Neurology, Neuroscience Institute, Hamad Medical Corporation, Doha, State of Qatar;

2. Department of Clinical Services Unit, Corporate Pharmacy, Hamad Medical Corporation, Doha, State of Qatar

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2018.1476334

Reference97 articles.

1. Persistence with and adherence to fingolimod compared with other disease-modifying therapies for the treatment of multiple sclerosis: a retrospective US claims database analysis

2. Comparison of adherence and persistence among multiple sclerosis patients treated with disease-modifying therapies: a retrospective administrative claims analysis

3. Systematic review of disease-modifying therapies to assess unmet needs in multiple sclerosis: tolerability and adherence

4. The STAR Study: A Real-World, International, Observational Study of the Safety and Tolerability of, and Adherence to, Serum-Free Subcutaneous Interferon β-1a in Patients With Relapsing Multiple Sclerosis

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing trustworthiness and reliability: advance explainable artificial intelligence framework for real world Sclerosis detection;Physica Scripta;2024-09-04

2. Oral cancer detection model in distributed cloud environment via optimized ensemble technique;Biomedical Signal Processing and Control;2023-03

3. Clinical use of dimethyl fumarate in multiple sclerosis treatment: an update to include China, using a modified Delphi method;Therapeutic Advances in Neurological Disorders;2023-01

4. Real-World Comparative Cost-Effectiveness Analysis of Different Classes of Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis in Saudi Arabia;International Journal of Environmental Research and Public Health;2021-12-16

5. Economic Evaluation of Cladribine Tablets in Patients With High Disease Activity–Relapsing-Remitting Multiple Sclerosis in the Kingdom of Saudi Arabia;Value in Health Regional Issues;2021-09